A novel class of geldanamycin derivatives as HCV replication inhibitors targeting on Hsp90 : synthesis, structure-activity relationships and anti-HCV activity in GS4.3 replicon cells
スポンサーリンク
概要
- 論文の詳細を見る
- 2011-02-25
著者
-
Meng Shuai
Institute of Medicinal Biotechnology, Chinese Academy of Medical Science and Peking Union Medical Co
-
Li Zhuo-rong
Institute Of Medicinal Biotechnology Chinese Academy Of Medical Science And Peking Union Medical Col
-
Li Dong
Institute Of Biochemistry And Molecular Biology Ningbo University School Of Medicine
-
Li Yu-huan
Institute Of Medicinal Biotechnology Chinese Academy Of Medical Sciences And Peking Union Medical College
-
Gao Lin-yan
Institute Of Medicinal Biotechnology Chinese Academy Of Medical Sciences And Peking Union Medical College
-
Shan Guang-zhi
Institute Of Medicinal Biotechnology Chinese Academy Of Medical Sciences And Peking Union Medical College
-
Li Yan-ping
Institute Of Medicinal Biotechnology Chinese Academy Of Medical Sciences And Peking Union Medical College
-
Peng Zong-gen
Institute Of Medicinal Biotechnology Chinese Academy Of Medical Sciences And Peking Union Medical College
-
JIANG Jian-dong
Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College
-
Jiang Jian-dong
Institute Of Medicinal Biotechnology Chinese Academy Of Medical Sciences And Peking Union Medical College
-
Meng Shuai
Institute Of Medicinal Biotechnology Chinese Academy Of Medical Sciences And Peking Union Medical College
関連論文
- Synthesis and Antiviral Activities of Synthetic Glutarimide Derivatives
- Development of a RP-HPLC method for screening potentially counterfeit anti-diabetic drugs
- Increased expression of miR-421 in human gastric carcinoma and its clinical association
- Synthesis, structures and anti-HBV activities of derivatives of the glutarimide antibiotic cycloheximide
- A novel class of geldanamycin derivatives as HCV replication inhibitors targeting on Hsp90 : synthesis, structure-activity relationships and anti-HCV activity in GS4.3 replicon cells
- Core-APOBEC3C chimerical protein inhibits hepatitis B virus replication